The Association of Racing Commissioners International on Wednesday approved model rules that would tighten the restrictions on using shock-wave therapy and would require racetracks to maintain logs of the people who enter backstretches late at night.
Trainers will need to pay a $100 nomination fee to make horses in their stables eligible for races in the Claiming Crown under new procedures adopted by the organizations that administer the seven-race event, the organizations said on Tuesday.
The Jockey Club has scheduled the fourth Welfare and Safety of the Racehorse Summit for Oct. 16-17 at Keeneland Racecourse in Lexington, Ky.
Penn National Gaming Inc., the owner of dozens of casinos across the U.S., had net income of $66.6 million in the second quarter of 2012, a 12.3 percent decline from net income of $76 million in the second quarter of last year.
The Jockey Club of Canada has revamped its media awards for 2012, reducing the number of categories from four to three while modifying the rules regarding submissions.
A group of 40 owners have signed a pledge to race their 2-year-old horses this year without raceday furosemide, the anti-bleeding medication that has been the topic of a heated debate in racing for the past year.
Churchill Downs Inc. is one of 30-plus companies to have submitted applications for an online poker license in Nevada, officials of the Nevada Gaming Control Board confirmed on Wednesday.
Sen. Tom Udall of New Mexico used a three-hour Senate hearing on Thursday to gauge the level of support in the racing industry for federal regulation, at times threatening to scuttle the industry's federal authority to conduct state-to-state simulcast wagering if it did not address critics of its medication policies and regulation.
Dr. Dionne Benson, a former lawyer who recently completed a veterinary internship at Rood and Riddle Equine Hospital, has been hired as the executive director and chief operating officer of the Racing Medication and Testing Consortium, the organization announced Wednesday.
The U.S. Senate Committee on Commerce, Science, and Transportation has scheduled a hearing on Thursday in Washington, D.C., to discuss “the prevalence and use of medication and performance-enhancing drugs in horse racing."
